Diamond Blackfan anemia treatment: past, present, and future
Anupama Narla, Adrianna Vlachos, David G Nathan, Anupama Narla, Adrianna Vlachos, David G Nathan
Abstract
Despite significant improvements in our understanding of the pathophysiology of Diamond Blackfan anemia (DBA), there have been few advances in therapy. The cornerstones of treatment remain corticosteroids, chronic red blood cell transfusions, and hematopoietic stem cell transplantation, each of which is fraught with complications. In this article, we will review the history of therapies that have been offered to patients with DBA, summarize the current standard of care, including management of side effects, and discuss novel therapeutics that are being developed in the context of the research into the roles of ribosomal haplo-insufficiency and p53 activation in Diamond Blackfan anemia.
Copyright © 2011 Elsevier Inc. All rights reserved.
Source: PubMed